The study will evaluate ruxolitinib (Jakavi) for the treatment of COVID-19-associated cytokine storm.
Facing disruptions in medical mask supplies, some hospital staff are re-using masks and using alternative types, according to a new survey.
Coronavirus News Roundup: FDA Emergency Use Authorizations, Vaccine Candidate, and Virtual Blood Drives
Here's a roundup of the latest coronavirus-related news.
Concerns about adequate protection from COVID-19 have led to several efforts from chain pharmacies to keep pharmacy staff and employees safe.
Johnson & Johnson expects to initiate human clinical studies for its lead COVID-19 vaccine candidate by September 2020.
Chloroquine and hydroxychloroquine have been authorized to treat hospitalized patients with COVID-19.
Abbott’s ID NOW COVID-19 test is able to deliver results in as little as 5 minutes.
Here’s a roundup of the latest coronavirus-related news from this week.
Gilead has now asked the FDA to rescind its orphan drug status for the potential COVID-19 therapy.
In a joint statement, the American Medical Association (AMA), American Pharmacists Association (APhA), and American Society of Health-System Pharmacists (ASHP) have communicated concerns regarding the inappropriate ordering, prescribing, or dispensing of treatments for COVID-19.